Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Induction Followed by Interferon-beta1b in Active RRMS
NCT00219908Phase 2Terminated
- Sponsor
- CHU Rennes
- Start
- Jul 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of mitoxantrone in relapsing-remitting multiple sclerosis (RRMS), sponsored by CHU Rennes. Started Jul 1999; status: terminated.
02
Drugs
mitoxantrone
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00219908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219908.